Details for Patent: 9,486,530
Which drugs does patent 9,486,530 protect, and when does it expire?
Patent 9,486,530 protects GANZYK-RTU and is included in one NDA.
Summary for Patent: 9,486,530
| Title: | Ganciclovir compositions and related methods |
| Abstract: | Gancyclovir formulations that are ready-to-use, substantially particulate free, and stable upon storage are disclosed. Methods of manufacture and administration of such compositions are also provided. |
| Inventor(s): | Sreerama Murthy Mallipeddi, Jonathan E. Sterling, Phanesh B. Koneru |
| Assignee: | Exela Pharma Sciences LLC |
| Application Number: | US14/475,206 |
|
Patent Claim Types: see list of patent claims | Use; Composition; |
Drugs Protected by US Patent 9,486,530
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Exela Pharma | GANZYK-RTU | ganciclovir | SOLUTION;INTRAVENOUS | 209347-001 | Feb 17, 2017 | DISCN | Yes | No | 9,486,530 | ⤷ Start Trial | Y | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
